Central America Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 58 pages

Includes 3 FREE quarterly updates

BMI View:
Favourable tax incentives, continued demand for both generic and patented medicines, andregional anti-counterfiet measures solidify Central America's revenue generating opportunities formultinational pharmaceutical companies in coming years. Despite political instability in some areas of theregion, Central America's medicine consumption will continue to grow in 2015.
Headline Expenditure Projections
- Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.1%. Our forecast has been maintainedsince Q215.- Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.1%. Our forecast has been revised upwardssince Q215 due to revised historical data.

Table Of Contents

Central America Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View ...... 7
SWOT ............ 9
SWOT .............. 9
Industry Forecast ..... 10
Pharmaceutical Market Forecast ....... 10
Table: Central America Pharmaceutical Sales, Historic Data And Forecasts . 12
Guatemala ..... 12
Table: Guatemala Pharmaceutical Sales Forecasts . . . . 12
Costa Rica ..... 13
Table: Costa Rica Pharmaceutical Sales Forecasts . . . . 13
El Salvador .... 13
Table: El Salvador Pharmaceutical Sales Forecasts . . . 14
Honduras ...... 14
Table: Honduras Pharmaceutical Sales Forecasts . . . . . 14
Panama ......... 14
Table: Panama Pharmaceutical Sales Forecasts . 15
Nicaragua ..... 15
Table: Nicaragua Pharmaceutical Sales Forecasts . . . . 15
Healthcare Market Forecast ............. 16
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts 17
Guatemala ..... 17
Table: Guatemala Healthcare Expenditure Forecasts . 18
Costa Rica ..... 18
Table: Costa Rica Healthcare Expenditure Forecasts . 18
El Salvador .... 18
Table: El Salvador Healthcare Expenditure Forecasts 19
Panama ......... 19
Table: Panama Healthcare Expenditure Forecasts . . . . 19
Honduras ...... 19
Table: Honduras Healthcare Expenditure Forecasts . . 20
Nicaragua ..... 20
Table: Nicaragua Healthcare Expenditure Forecasts . . 20
Pharmaceutical Trade Forecast ........ 21
Guatemala ..... 23
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn) . . . . . 23
Costa Rica ..... 23
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn) . . . . . 23
El Salvador .... 24
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn) . . . . 24
Panama ......... 24
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn) . . 25
Honduras ...... 25
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn) 25
Nicaragua ..... 26
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn) 26
Industry Risk Reward Ratings 27
Americas Risk/Reward Index ............ 27
Central America Risk/Reward Index ... 32
Rewards ........ 33
Risks ............. 33
Industry Trends And Developments ..... 34
Epidemiology . 34
Healthcare Sector .......... 35
Guatemala ..... 36
Costa Rica ..... 37
El Salvador .... 38
Panama ......... 39
Honduras ...... 39
Nicaragua ..... 40
Clinical Trials 41
Regulatory Development ........ 43
Intellectual Property Regime ........... 43
Costa Rica ..... 44
El Salvador .... 45
Honduras ...... 45
Nicaragua ..... 46
Guatemala ..... 46
Competitive Landscape .......... 47
Company Profile ....... 48
Ancalmo Internacional ..... 48
Donovan Werke 50
Glossary ..... 52
Methodology ............. 54
Pharmaceutical Expenditure Forecast Model .... 54
Healthcare Expenditure Forecast Model ........... 54
Notes On Methodology .... 55
Risk/Reward Index Methodology ...... 56
Index Overview .............. 57
Table: Pharmaceutical Risk/Reward Index Indicators . 57
Indicator Weightings ...... 58

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • February 2015
  • by Global Data

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, ...

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

  • $ 6 650
  • Industry report
  • May 2015
  • by BCC Research

This BCC Research study provides an in-depth analysis and forecast of selected areas of the global healthcare acquired infections (HAI) market. The report offers forecasts by treatment segment and type ...

Working Capital Management in the North American and European Pharmaceutical Industry : Optimization is the Key to Working Capital Efficiency

Working Capital Management in the North American and European Pharmaceutical Industry : Optimization is the Key to Working Capital Efficiency

  • $ 6 000
  • Industry report
  • April 2015
  • by Frost & Sullivan

Executive Summary Need for Effective Working Capital Management •Decreasing profitability •Fizzling innovation model •Access to new markets •Price premium pressure Key Trends •The analysis of ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.